[Results of the clinical experimentation with CB 4261 (Tetrazepam) affecting spasticity in neurologic diseases. Use of secondary effects (56 cases)].
D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D009422:Nervous System Diseases / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D009125:Muscle Relaxants, Central; D014149:Tranquilizing Agents
Résultats de l'expérimentation clinique du 4261 CB (tetrazepam) sur la spasticité dans les affections neurologiques. Utilisation des effets secondaires (56 observations)